Pinebridge Investments L.P. Boosts Stock Position in Cabot Co. (NYSE:CBT)

Pinebridge Investments L.P. grew its holdings in Cabot Co. (NYSE:CBT - Free Report) by 42.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 22,076 shares of the specialty chemicals company's stock after purchasing an additional 6,604 shares during the period. Pinebridge Investments L.P.'s holdings in Cabot were worth $2,016,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Barclays PLC lifted its holdings in Cabot by 103.9% during the 3rd quarter. Barclays PLC now owns 113,614 shares of the specialty chemicals company's stock valued at $12,699,000 after buying an additional 57,907 shares in the last quarter. World Investment Advisors LLC bought a new stake in shares of Cabot during the third quarter valued at approximately $3,161,000. Wilmington Savings Fund Society FSB purchased a new stake in shares of Cabot in the third quarter valued at approximately $1,651,000. Tidal Investments LLC grew its stake in Cabot by 2.9% in the third quarter. Tidal Investments LLC now owns 11,917 shares of the specialty chemicals company's stock worth $1,332,000 after purchasing an additional 340 shares in the last quarter. Finally, Franklin Resources Inc. purchased a new position in Cabot during the 3rd quarter worth $654,000. 93.18% of the stock is currently owned by institutional investors.

Cabot Stock Performance

Shares of Cabot stock opened at $79.27 on Monday. Cabot Co. has a one year low of $73.63 and a one year high of $117.46. The company has a market capitalization of $4.30 billion, a PE ratio of 10.53, a P/E/G ratio of 0.74 and a beta of 1.04. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.29 and a current ratio of 2.00. The company has a 50-day simple moving average of $81.93 and a two-hundred day simple moving average of $93.57.

Cabot (NYSE:CBT - Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. Research analysts expect that Cabot Co. will post 7.57 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently issued reports on CBT. JPMorgan Chase & Co. dropped their price target on Cabot from $105.00 to $85.00 and set an "underweight" rating on the stock in a research report on Friday, February 21st. StockNews.com raised shares of Cabot from a "hold" rating to a "buy" rating in a research report on Thursday, April 17th. UBS Group lowered their price target on shares of Cabot from $93.00 to $83.00 and set a "neutral" rating for the company in a research report on Monday, April 7th. Finally, Mizuho cut their price objective on shares of Cabot from $122.00 to $110.00 and set an "outperform" rating on the stock in a report on Tuesday, January 7th.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.